Skip to playerSkip to main content
  • 14 years ago
Recently evidence has shown that patients taking the Type 2 Diabetes drug Actos for more than one year have a 40% increased risk of bladder cancer. Actos has been pulled from the markets in both Germany and France.
Be the first to comment
Add your comment

Recommended